Research Trials for People with hEDS
Many people with hypermobile Ehlers-Danlos syndrome (hEDS) wonder whether research trials can offer new hope, better care, or a chance to help others. Although hEDS is under-researched compared to other chronic conditions, the number of trials is increasing—slowly—and new tools like telemedicine and online registries are making it easier to participate. This article explains how research trials work for people with hEDS, what they typically study, how to find and enroll in one, what they cost (if anything), and what participants might gain.
Overview of Where Trials Happen and Who Runs Them
Research trials for hEDS in the U.S. usually take place at
Large academic medical centers
University hospitals
Connective tissue disorder clinics
Pediatric hospitals (for studies involving children)
Principal investigators (the doctors or researchers who lead the study) are most often:
Medical geneticists
Rheumatologists
Pediatric rheumatologists
Depending on the topic, research teams may also include
Physical therapists
Cardiologists
Pain management specialists
Orthopedic surgeons
Psychologists or psychiatrists
Internationally, the situation is similar, though national health systems (e.g., in the UK or Canada) often make it easier to centralize research efforts and patient recruitment.
What Are Trials Studying?
The most common topics studied in hEDS research include
Pain management and fatigue
Physical therapy and exercise outcomes
Mental health, functional ability, and quality of life
Diagnostic criteria and classification
Comorbidities such as POTS or mast cell activation
Healthcare access, misdiagnosis, or costs
Genetics and molecular pathways (although no hEDS gene has yet been identified)
Estimated Distribution of hEDS Research Topics (U.S. and international combined)
Based on available studies from sources like ClinicalTrials.gov, published literature reviews, and EDS Society summaries, approximate topic distribution is as described in the following chart.
Research Area | Estimated % of Trials | Notes |
Symptom management (pain, fatigue, etc.) | 30–35% | Includes physical therapy, pain management, and exercise interventions |
Quality of life, functional capacity, mental health | 20–25% | Often measured through surveys and validated scales |
Diagnostic criteria and classification | 10–15% | Includes efforts to refine or validate hEDS diagnosis |
Genetics and molecular research | 5–10% | Small percentage; no gene has yet been found for hEDS |
Comorbidities (e.g., POTS, MCAS, psychiatric issues) | 10–15% | Only if studied specifically in hEDS patients |
Epidemiology and healthcare utilization | 5–10% | Looks at prevalence, misdiagnosis, and healthcare access |
Study Types and How They Work
Because hEDS is rare and complex, most U.S. studies use observational designs such as
Surveys or questionnaires
Registries (databases of people with hEDS who agree to be contacted)
Medical chart reviews
Interventional studies—where researchers test a treatment or therapy—are less common, but may include
Exercise or physical therapy programs
Rehabilitation or pain management techniques
Surgical or device-related outcomes (very rare)
Most interventional studies are small, non-randomized, and open-label (meaning everyone knows what treatment is being used).
What Happens When Someone Finds a Trial?
Once a person identifies a research study they may qualify for, the next steps typically include
Contacting the research coordinator or study site listed in the study posting (e.g., on ClinicalTrials.gov).
A phone or email screening to check eligibility based on diagnosis, age, symptoms, and health history.
Scheduling a baseline visit (in person or remote) to provide informed consent and complete assessments.
Ongoing participation depending on the study (may include surveys, clinic visits, telehealth sessions, imaging, physical exams, or treatment protocols).
The study team explains everything in plain language before asking anyone to sign up. Participation is always voluntary.
Consent and Ethics for Adults and Children
In the U.S., all research studies must be approved by an Institutional Review Board (IRB), which ensures safety, fairness, and clarity.
For adults (18+)
Informed consent must be given in writing
Participants are told about risks, benefits, procedures, and alternatives
No one is required to join, and they can withdraw at any time
For children (under 18)
A parent or guardian must give permission
The child must also give assent (agree to join), usually if they’re age 7 or older and capable of understanding
Researchers are trained to explain studies in developmentally appropriate ways. No child is forced to participate.
What Participation Involves
Study visits vary widely depending on the type of study. Some involve a one-time survey. Others include months of physical therapy or follow-up.
Participation might include activities such as
Joint exams and Beighton score testing
Bloodwork or imaging (e.g., X-rays, MRIs)
Questionnaires on fatigue, pain, anxiety, or functioning
Wearing a monitor or device for a few days
Physical therapy sessions at home or in a clinic
In pediatric studies, there may also be neurodevelopmental assessments.
Benefits to Participants
Direct benefits may include
Physical therapy tailored to hEDS
Pain or fatigue reduction
Education or monitoring not available elsewhere
Help from an expert team
Some participants report better posture, less fatigue, and better function months after completing a study.
Some find value in being heard and helping future patients.
Indirect benefits include
Contributing to medical understanding
Being connected to other people with hEDS
Finding providers who understand the condition
Risks and Downsides
Risks are typically low, but possible downsides include
Fatigue or injury during physical testing or therapy
Discomfort with assessments or questions
No personal benefit from participation
Time, travel, or childcare burdens
Who Pays and What’s Covered?
In the U.S., many academic and NIH-funded trials reimburse for
Travel and parking
Lodging (for long-distance participants)
Indirect costs—like lost wages, childcare, or non-covered care—may not be reimbursed. Some trials offer stipends.
Federal law requires most insurance plans to cover routine medical care received as part of a clinical trial. Medicaid and Medicare also provide this coverage.
Remote and Telehealth Options
Because people with hEDS may be geographically spread out or have mobility limitations, many new trials are using
Online surveys
Electronic consent (eConsent)
Telemedicine visits
Hybrid models (some in-person, some virtual)
This has improved access, especially for rural patients or those with fatigue and pain.
How Many Trials Are There?
The number of hEDS-specific trials is increasing but still small.
In a typical year, 3–7 trials in the U.S. are active or recently completed. A few more may exist internationally.
Most are observational, with fewer interventional studies.
How to Find a Trial
Use ClinicalTrials.gov and search “Ehlers-Danlos syndrome hypermobile”
The EU Clinical Trials Register registers participants for international studies
The WHO ICTRP covers global trials
The Ehlers-Danlos Society posts research opportunities
Patients can ask their doctor or join patient registries directly to hear about studies.
Summary
Research trials for hEDS are still relatively few, but growing. Most focus on pain, fatigue, physical therapy, or improving daily life—not just genetics or diagnosis. Patients who participate may benefit directly or indirectly. Academic centers, children’s hospitals, and online tools all play a role in making these studies possible. To find a study, start at ClinicalTrials.gov or the Ehlers-Danlos Society’s website.
Increasing patient-centered design, remote access, and inclusion will be key to building better trials for people with hEDS in the future.
